Determining exposure underreporting in pharmacoepidemiologic case-control studies: methods and example (Q44620193)

From Wikidata

Revision as of 03:58, 14 December 2023 by KrBot (talk | contribs) (‎Set a claim value: title (P1476): Determining exposure underreporting in pharmacoepidemiologic case-control studies: methods and example)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published in December 1999

Language	Label	Description	Also known as
English	Determining exposure underreporting in pharmacoepidemiologic case-control studies: methods and example	scientific article published in December 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Determining exposure underreporting in pharmacoepidemiologic case-control studies: methods and example (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

author name string

Lane DA

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Kramer MS

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Journal of Clinical Epidemiology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1279-1287

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900112-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Aminorex and the pulmonary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900112-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug-induced Pulmonary Hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900112-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary hypertension and fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900112-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Irreversible pulmonary hypertension after treatment with fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900112-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary pulmonary hypertension and fenfluramine use

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900112-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0895-4356(99)00112-2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44620193&oldid=2029534776"